Barely Significant
← all excerpts

A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus.

PLoS Pathog · 2025 · PMC12270161 · PMID 40674411

Europe PMCDOI
1
hedged sentence
0.0003
closest p · 0.0× alpha
0.0003
boldest claim

The sentences

highly significantp = 0.0003actually significant
Statistical comparison of the neutralising immune response elicited by VXB-221 to comparator hMPV F DSCavEs2 showed a highly significant difference (Mann Whittney Test; p = 0.0003).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.